SLC7A5 and central nervous system cancer: Higher levels of LAT1 are positively correlated with increased biological aggressiveness and higher mortality in a range of human cancers including gliomas, breast, lung, prostate, and ovarian cancers and is thus a promising target for tumor imaging and therapy [2,9-12].